VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the 29th Annual Canaccord Adams Global Growth Conference on Wednesday, August 12, 2009 at 1:00 PM (EDT) at the InterContinental Hotel in Boston, Massachusetts.
